Therefore, validation on the immune infiltration features of ICC with PD-L1, HHLA2 expression in another independent ICC cohort as well as further investigation on its molecular basis will provide more solid evidence. The gene discussed is HHLA2; the disease is intrahepatic cholangiocarcinoma.